|
Emmessar Biotech & Nutrition Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
17.08 Cr.
|
P/BV
|
2.22
|
Book Value (Rs.)
|
15.43
|
|
52 Week High/Low (Rs.)
|
64/27
|
FV/ML
|
10/1
|
P/E(X)
|
54.08
|
|
Bookclosure
|
29/09/2023
|
EPS (Rs.)
|
0.63
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 0.96 | 0.81 | 0.97 | 0.93 | 2.25 |
| | | | | | |
| Net CashFlow From Operating Activities | 0.22 | 0.64 | 0.38 | 2.27 | 0.47 |
| Net Cash Used In Investing Activities | -0.23 | -0.64 | -0.55 | -2.61 | 0.01 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.00 | 0.00 | -0.17 | -0.34 | 0.48 |
| Cash And Cash Equivalents Begin of Year | 0.01 | 0.01 | 0.18 | 0.53 | 0.05 |
| Cash And Cash Equivalents End Of Year | 0.01 | 0.01 | 0.01 | 0.18 | 0.53 |
